CCEL

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.07
Percentage change -0.82	%

Peers: CYRX VERU KRYS COOP KOD MRNS ARCT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.08	Insider Own	60.46%	Shs Outstand	8.06M	Perf Week	-10.97%
Market Cap	62.65M	Forward P/E	65.29	EPS next Y	0.12	Insider Trans	0.00%	Shs Float	3.19M	Perf Month	-14.56%
Income	-8.93M	PEG	-	EPS next Q	0.02	Inst Own	6.10%	Short Float	0.63%	Perf Quarter	23.97%
Sales	31.84M	P/S	1.97	EPS this Y	133.33%	Inst Trans	0.99%	Short Ratio	1.03	Perf Half Y	-4.10%
Book/sh	-1.19	P/B	-	EPS next Y	-68.42%	ROA	-13.45%	Short Interest	0.02M	Perf Year	18.71%
Cash/sh	0.27	P/C	29.41	EPS next 5Y	-	ROE	-	52W Range	4.47 - 9.50	Perf YTD	36.26%
Dividend Est.	-	P/FCF	20.28	EPS past 5Y	-58.40%	ROI	-	52W High	-17.51%	Beta	0.50
Dividend TTM	0.25 (3.19%)	Quick Ratio	0.57	Sales past 5Y	-0.26%	Gross Margin	71.87%	52W Low	75.08%	ATR (14)	0.42
Dividend Ex-Date	Nov 15, 2024	Current Ratio	0.61	EPS Y/Y TTM	-459.94%	Oper. Margin	-0.44%	RSI (14)	42.91	Volatility	3.51% 5.04%
Employees	88	Debt/Eq	-	Sales Y/Y TTM	1.95%	Profit Margin	-28.04%	Recom	1.00	Target Price	9.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	57.72%	Payout	-	Rel Volume	0.34	Prev Close	7.90
Sales Surprise	0.88%	EPS Surprise	333.33%	Sales Q/Q	2.50%	Earnings	Oct 15 AMC	Avg Volume	19.57K	Price	7.84
SMA20	-7.47%	SMA50	3.48%	SMA200	5.83%	Trades		Volume	6,563	Change	-0.82%

Oct-30-24 08:45AM	Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend (Business Wire) +25.60%
Oct-15-24 05:20PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results (Business Wire) +6.98%
Jul-15-24 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results (Business Wire) -6.07%
Apr-15-24 05:00PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results (Business Wire) -5.37%
Mar-25-24 09:00AM	Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value (Business Wire) +7.64%
05:00PM	Loading…
Feb-28-24 05:00PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 (Business Wire)
Jan-22-24 04:15PM	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET (GlobeNewswire)
Oct-12-23 04:45PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results (Business Wire)
Jul-14-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results (Business Wire) -9.50%
Apr-21-23 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results (Business Wire) +14.74%
Feb-28-23 05:15PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022 (GlobeNewswire)
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Oct-14-22 04:15PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-22-22 06:00PM	Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend (GlobeNewswire) +15.38%
Aug-17-22 05:00PM	Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange (GlobeNewswire) +10.36% -7.65%
04:30PM	Loading…
Jul-11-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results (GlobeNewswire)
Apr-13-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results (GlobeNewswire)
Mar-16-22 04:30PM	Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service (GlobeNewswire)
Mar-09-22 04:15PM	Cryo-Cell Shares Its 2021 Annual Letter to Shareholders (GlobeNewswire)
Feb-22-22 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021 (GlobeNewswire) +7.00% -10.03%
Oct-27-21 04:15PM	Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials (GlobeNewswire)
Oct-15-21 04:36PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results (GlobeNewswire)
Sep-20-21 06:05PM	Cryo-Cell International Announces Changes To Its Board of Directors (GlobeNewswire) -5.45% +6.51%
Aug-30-21 09:00AM	Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market (GlobeNewswire) +7.82%
Aug-20-21 09:04AM	Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies (GlobeNewswire)
Aug-11-21 12:03PM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021 (Newsfile)
09:00AM	Cryo-Cell International to Present at the Q3 Virtual Investor Summit (GlobeNewswire)
Jul-15-21 07:27PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results (GlobeNewswire)
May-10-21 09:00AM	Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials (GlobeNewswire)
Apr-14-21 06:14PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results (GlobeNewswire)
09:30AM	Loading…
Feb-26-21 09:30AM	Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University (GlobeNewswire) +11.11%
Feb-24-21 04:30PM	Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2020 (GlobeNewswire)
Oct-15-20 04:39PM	Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2020 Financial Results (GlobeNewswire)

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mikulinsky Oleg	Chief Information Officer	Nov 12 '24	Option Exercise	3.77	20,000	75,400	104,349	Nov 14 05:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cryo-Cell International, Inc

Upgrade your FINVIZ experience